Get 250+ investors tailored to your startup

Invest in your industry and stage
Emails & contact info included
Excel and CSV export
Automatically

Trusted by 3,000+ startups

Top 50 Medical VC (Venture Capital) Funds in Germany in May 2025

Last updated: May 2025 A list of 50 VC (Venture Capital) funds that invest in Medical startups based in Germany. We rank investors based on the number of investments they made in Medical companies from Germany. We update this investor list every month.

Top 50 Medical VC (Venture Capital) Funds in Germany in May 2025

Investor	Medical Germany investments
High-Tech Gruenderfonds	19
Bayern Kapital	13
KfW	11
BioMedPartners	7
NRW.BANK	7
MIG Capital	7
Wellington Partners	6
TGFS - Technologiegründerfonds Sachsen	6
b2venture	6
Calm/Storm Ventures	5
Possible Ventures	5
bm-t beteiligungsmanagement thuringen	5
Rheingau Founders	5
Picus Capital	5
HV Capital	5
IBB Ventures	5
Atlantic Labs	4
Brandenburg Kapital	4
EQT Life Sciences	4
seed + speed Ventures	4
Heal Capital	4
Boehringer Ingelheim Venture Fund	3
DvH Ventures	3
Global Asset Fund	3
Born2Grow	3
IFB Innovationsstarter	3
LSP BioVentures	3
SOSV	3
German Federal Ministry of Education and Research	3
UNIQA Ventures	3
VI Partners	3
WestTech Ventures	3
Playground Global	3
Vorwerk Ventures	3
Forbion Capital Partners	3
Bertelsmann Investments	3
Vesalius Biocapital Partners	3
BayBG Venture Capital	3
Sparkasse Jena	3
BackBone Ventures	2
Lauder Partners	2
TUDAG	2
Global Life Science Ventures	2
WEGVISOR	2
Antler	2
Springboard Health Angels	2
DocCheck Guano AG	2
Auxxo	2
APEX Ventures	2
KHAN Technology Transfer Fund	2

Find investors that fund startups like yours. Automatically.

Our algorithm will find investors that invest in your industry, stage, and geography.

Investor list

The seed investor High-Tech Gründerfonds (HTGF) finances tech start-ups with growth potential and has supported more than 700 start-ups since 2005. With the launch of its fourth fund, HTGF now has about 1.4 billion euros under management. Its team of experienced investment managers and start-up experts support young companies with expertise,entrepreneurial spirit and passion. HTGF’s focus is on high-tech start-ups in the fields of digital tech, industrial tech, life sciences, chemistry and related business areas. To date, external investors have injected about 5 billion euros of capital into the HTGF portfolio via more than 2,000 follow-on financing rounds. In addition, HTGF has already successfully sold shares in more than 170 companies. Fund investors in this public-private partnership include the German Federal Ministry for Economic Affairs and Climate Action, KfW Capital and 45 companies from a wide range of industries. Fund investors in this public-private partnership include the German Federal Ministry for Economic Affairs and Climate Action, KfW Capital and 45 companies from a wide range of industries.

Investment focus

Software, Biotechnology, Information Technology
Seed, Series A, Funding Round
Germany, Switzerland, United States

Portfolio highlights

mo:re GmbH — Mo:re is building the new gold standard for organoid-based drug development by offering a lab platform that industrialises cell culture workflows.
Eyeo — eyeo revolutionizes imaging with color splitter sensors. Capture sharper, brighter images in low light using optical waveguide innovation, discover how it works
AICA SA — AICA believes programming robots should be at everyone's reach. We combine Artificial Intelligence & an intuitive interface, to help you relocate your production.

Bayern Kapital (founded at the end of 1995) is a wholly owned subsidiary of the LfA Foerderbank Bayern (Bavaria‘s development bank). Bayern Kapital’s objective is to finance research and development as well as the market launch of new products, product diversifications, and expansion of the market share.The requesting company has to be located inBavaria. Industries are e. g. IT/software, life sciences, new materials, micro-systems and environmental technologies.Bayern Kapital and its funds have invested in more than 250 companies and currently manages funds to the value of EUR 340 m. The five investing funds currently managed by Bayern Kapital are Seedfonds Bayern, Clusterfonds Start-Up!, Innovationsfonds, Innovationsfonds EFRE and Wachstumsfonds Bayern.

Investment focus

Software, Health Care, Information Technology
Seed, Series A, Funding Round
Germany, United States, Finland

Portfolio highlights

AlfaDocs — Il primo software in cloud pensato per la gestione completa dello studio medico e dentistico e della relazione medico-paziente. Provalo subito gratis!
OroraTech — From safeguarding forests and ecosystems to protecting communities and critical assets, OroraTech's advanced technology and reliable insights address challenges, mitigate risks, and drive meaningful impact.
Ubimaster — Ubimaster provides personalised employee benefits and additional product services that support parents and students.

KfW gives impetus to economic, social and ecological development worldwide. As a promotional bank under the ownership of the Federal Republic and the LÃ¤nder (federal states), it offers support to encourage sustainable improvement in economic, social, ecological living and business conditions, among others in the areas of small and medium-sizedenterprise, entrepreneurialship, environmental protection, housing, infrastructure, education finance, project and export finance, and development cooperation.

Investment focus

Biotechnology, Software, Health Care
Funding Round, Series A, Series B
Germany, India, Kenya

Portfolio highlights

Vectoflow — Vectoflow is an innovative company developing fluid-dynamic metrology devices for fluid flow and dynamics measurement. It offers standardized and customized flow measurement technology that measures the static and total pressure, velocity, and angle of attack of a flow. These products are used in motorsport, aviation, turbine machine development,and research sectors.
Electrochaea — Electrochaea is commercializing a disruptive, scalable technology to convert electric power into methane, the principal component of natural gas. Using CO2 as a feedstock gas, power can be efficiently converted to renewable natural gas for power storage, for transportation fuels, or for transmission via a natural gas network. The company licensedtechnology from the University of Chicago and is led by the Nidus Partners, a St. Louis investment group specializing in renewable energy. Mich Hein, a Nidus Managing Partner, serves as CEO.Electrochaea has developed a commercially viable and disruptive solution for utility-scale energy storage, grid balancing, and carbon reuse. Their proprietary process converts low-cost and stranded electricity and carbon dioxide into pipeline-grade renewable gas for direct injection into the existing natural gas grid, a conversion process known as “power-to-gas”.
CryoTherapeutics — USING CRYOTHERAPY TO TREAT AND PREVENT HEART ATTACKS

BioMedPartners is one of the leading European venture capital firms providing private equity and mezzanine financing to early- and mid-stage healthcare and human life science companies. They target the entire industry with special focus on pharmaceuticals, biotechnology, diagnostics and medical technology.

Investment focus

Biotechnology, Health Care, Medical
Series A, Series B, Series C
Switzerland, Germany, France

Portfolio highlights

ImmunOs Therapeutics — ImmunOs Therapeutics AG is a clinical-stage biotechnology company focused on discovering and developing next generation and novel human immunomodulatory proteins with a role in both innate and adaptive immunity.Their mission is to develop the next generation of novel therapeutics that will improve the lives of patients with serious disease.
TOLREMO therapeutics — TOLREMO therapeutics is striving to prevent the development of cancer therapy resistance through its proprietary drug discovery and development platform. Learn more about us.
Tubulis — Reimagining Antibody Drug Conjugates Tubulis generates uniquely matched protein-drug conjugates through the combination of novel proprietary technologies and disease-specific biologic insight. Our goal is to expand the therapeutic potential of antibody-drug conjugates (ADCs) by increasing design flexibility while overcoming constraints of toxicity, efficacy and indication. Tubulis will build new conjugates to fill its pipeline and

NRW.BANK is the development bank for the state of North Rhine-Westphalia. It supports its owner – the state of North Rhine-Westphalia – in fulfilling its tasks, notably in the fields of structural, economic, social and housing policy. NRW.BANK pools the promotion and development programmes of the state of North Rhine-Westphalia, the FederalRepublic of Germany and the European Union and combines them with its own equity and debt products and advisory services. It offers the full range of financial products in three areas “Economy”, “Housing”, and “Infrastructure/Municipalities”. NRW.BANK operates in a competitively neutral manner as a partner of banks and savings banks.

Investment focus

Software, Biotechnology, Information Technology
Seed, Series A, Series B
Germany, United States, France

Portfolio highlights

Pilzling — Bio-Pilze direkt aus deiner Stadt.
ScrapBees — ScrapBees is a pick-up service for the recycling of scrap metal from commercial businesses and private households.
Alteva — Alteva develops battery cells for the decarbonisation of the global transport sector, and focus on high-energy density battery cells with high safety profiles specifically designed for the aviation and heavy-duty transport sectors.

Zusammen gestalten wir die Unternehmen von morgen.

Investment focus

Biotechnology, Health Care, Medical
Series A, Funding Round, Series B
Germany, France, Austria

Portfolio highlights

Inbolt — InBolt has developed the world’s smallest and most efficient 3D camera tracking system. Their first product is a hardware module / device that an operator can plug onto all manual tools such as a drill, a screwdriver or a torque wrench. Once on the tool, it guides the operator, validates the completion of a task in real time and registers allthe completion parameters.
SciRhom — SciRhom GmbH is a biotech company that translates science into the preclinical and early clinical development of novel biopharmaceuticals for the treatment of life-threatening autoimmune diseases. Based on longstanding academic research and a well-established network of experts, SciRhom was founded in 2016 through a collaboration between academicand industry scientists with profound experience in antibody development.
Innatera — Innatera is a Dutch nanotech company and an offspring of the Delft University of Technology in the Netherlands.

Wellington Partners is a venture capital firm that invests in technology and life sciences companies, focusing on Digital Media, Software, Electronics & Photonics, Resource Efficiency, and Biotech/Life Sciences. It is committed to providing outstanding entrepreneurs with the necessary resources to fund their strategies. We typically leadfinancing rounds ranging from € 0.5 million to € 20 million. Depending on the maturity of the company, its own commitment can go as high as € 15 million.Wellington was established in 1998 and has offices in Munich, London, and Zurich.

Investment focus

Health Care, Biotechnology, Medical
Series A, Series B, Funding Round
Germany, United States, United Kingdom

Portfolio highlights

Hilo — Get stress-free readings round the clock with Hilo's clinically validated blood pressure monitor. Learn more
Aignostics — Aignostics is an AI-powered precision diagnostics focused on pathology to assist with drug development and clinical research. Its “explainable” AI overcomes the “black-box” limitations of conventional AI. Based on their patented technology for reverse-engineering the black box, they render diagnostic results explainable in the form of preciseheatmaps and image overlays. These heatmaps allow pathologists to quickly verify the results of the AI, which is crucial, as the pathologist is ultimately responsible for the diagnosis.The company was founded in 2018 and is headquartered in Berlin, Germany.
HepaRegeniX — HepaRegeniX is developing drugs for treating acute and chronic liver diseases that effectively restore the regenerative capacity of hepatocytes. The therapeutic concept is founded on research by Professor Lars Zender’s group at the University Hospital Tübingen, which identified mitogen-activated protein (MAP) kinase kinase 4 (MKK4) as a keyregulator of liver regeneration. Work by Professor Zender’s team showed that using small RNA molecules to suppress MKK4 gene expression restored the regenerative capacity of hepatocytes, even in severely diseased livers. Founded in 2015, HepaRegeniX is developing small-molecule MKK4 inhibitors to treat liver disorders, potentially including nonalcoholic steatohepatitis.

TGFS - Technologiegruenderfonds Sachsen is an early stage VC fund targeting high tech startups with strong growth potential. The fund invests into ventures located in Saxony/Germany, Europe's leading semiconductor cluster. The team has invested into more than 120 companies so far, including more than 40 investments from the currentfund.

Investment focus

Software, Information Technology, Health Care
Seed, Series A, Funding Round
Germany, United States

Portfolio highlights

Zepta — Zepta emphasizes "digital solutions and sustainability in pest control." Zepta develops a digital approach for protecting humans from pests.
Prodlane — B2B Product Management SaaS solution
LipoCheck — LipoCheck is a healthtech startup that focuses on improving the diagnosis and treatment of lipedema, a condition that affects millions of women. The company offers a digital platform that serves as a support system for patients and treating physicians. LipoCheck's services include helping patients recognize lipedema and providing assistance inbecoming symptom-free. The platform was developed with the experiences of practicing doctors, product managers, and software developers. In addition to its digital services, LipoCheck also offers a range of merchandise including hoodies and shirts.

B2venture is a venture capital firm focused on early-stage investments in digital and industrial technology companies. B2venture invests EUR 100m+ per year in high-growth companies with ticket sizes from EUR 0.25m to 3.5m.

Investment focus

Software, Health Care, Artificial Intelligence
Series A, Seed, Series B
Germany, Switzerland, United Kingdom

Portfolio highlights

Nelly — Nelly provides tool for medical practices that simplifies patient onboarding and payments.
1Komma5° — KOMMA5 ° offers all owners of electric vehicles free electricity, which we refinance through trading with so-called GHG quotas. 1KOMMA5 ° encourages to lead a self-determined and CO2-neutral life.
assemblean — assemblean goal is to construct the digital manufacturing infrastructure of the future. We want to make it possible for everyone to build physical items as readily as software.

Calm/Storm is an exclusive founder network and venture capital firm. We invest in purpose driven founders changing our life & health for the better. Headquartered in Vienna, Austria we invest in early-stage companies all over Europe and the US. We focus on the pre-seed and seed stages but also invest up to Series A.

Investment focus

Health Care, Wellness, Software
Seed, Pre-Seed, Series A
United Kingdom, Germany, Austria

Portfolio highlights

Sugar — Sugar a digital halth and fitness paltform.
ginkgo — ginkgo is the digital platform for holistic compensation packages starting with company pension plans (bAV).
Everyman Health — Everyman Health ist Spezialist für Männergesundheit und bietet wissenschaftlich fundierte Lösungen für Männer aller Altersgruppen. In Zusammenarbeit mit unseren Partnern, bieten wir dir ein umfassendes Portfolio von digitalen, medikamentösen und nicht-medikamentösen Therapien für unterschiedliche Männerprobleme.Über unsere Plattform wirst du inwenigen Minuten mit einem Schweizer Facharzt verbunden und erhältst eine persönliche Diagnose und gegebenenfalls ein Rezept.Auf Wunsch wird deine persönliche Behandlung von einer lizenzierten Schweizer Apotheke diskret verpackt und dir kostenlos bis vor die Haustür geliefert.

Possible Ventures backs ambitious teams building frontier technology to positively impact society. We invest globally in the early stages, actively supporting founders via our collective of global entrepreneurs.

Investment focus

Software, Information Technology, Biotechnology
Seed, Pre-Seed, Series A
Germany, Australia, United States

Portfolio highlights

Heidi Health — Heidi Health is modernizing primary care with AI-powered technologies to improve care's quality and accessibility. its creators and engineers is to completely eradicate missed and sluggish diagnoses worldwide. They are committed to bridging the gap between the level of care that patients desire and the level of care that doctors can delivergiven their budget constraints. To create a platform where patients can quickly and easily get the treatment they require and to give every clinician the resources they need to deliver care that is secure, efficient,
HyperHeat — HyperHeat is a climate tech startup, that develops a breakthrough solution for zero-carbon industrial heat at very high temperatures.
Hippos Exoskeleton — Hippos Exoskeleton created an auto-inflating knee brace to avoid tears in the ACL and other injuries.

bm|t supports innovative and growth-oriented companies in Thuringia with equity investments and venture capital.

Investment focus

Software, Information Technology, Health Care
Seed, Funding Round, Series A
Germany, United States

Portfolio highlights

rooom — rooom is a global startup based in Germany, launched in 2019. The company’s experienceCloud is an all-in-one platform for creating, managing and promoting engaging 2D, 3D, AR & VR experiences. It works across all desktop and mobile devices. rooom’s experienceCloud is designed to cover the marketing and visualization needs of differentindustries through their comprehensive product portfolio. These include eventCloud (optimized for virtual events, exhibitions, conferences, meetings), spaceCloud (real estate, property, museums), productCloud (3D products, product showrooms) and immerseCloud (tours, guides, 3D books). rooom’s eventCloud is routinely hosting up to 200,000 users for hybrid events like IFA, Berlin and for global customers such as Porsche, Deutsche Telekom, DHL and E.ON. rooom has won over 20 awards, including the Global Eventex Award (twice), the Innovation & Excellence Award and the German Innovation Award.
Zepta — Zepta emphasizes "digital solutions and sustainability in pest control." Zepta develops a digital approach for protecting humans from pests.
Enginsight — Enginsight GmbH was founded in August 2017. With a highly motivated team, they are working together on the vision of providing companies with a solution that will enable them to safely and confidently navigate the digital future. Enginsight helps leading companies autonomously monitor and secure their entire IT landscape. Certified and highlytrained employees form the heart of Enginsight, together with partner companies around the globe. They analyze and monitor complete IT landscapes – recognize the connections and dependencies between websites and servers up to IoT-devices. The innovative software platform acts autonomously and points out the critical paths, risks and threats.

Rheingau Founders is a Berlin&Munich based Venture Capital firm active since 2011. Focusing on pre-seed to Series A investments in Europe, predominantly B2B in the fields of Marketplaces, Software as a Service, InsurTech, and eHealth. Rheingau targets start-ups that have the potential to sustainably disrupt existing processes and value chains.Besides the financial investment, we offer strategic support through the mentorship of our partners.

Investment focus

Software, E-Commerce, Internet
Seed, Series A, Pre-Seed
Germany, United States, Poland

Portfolio highlights

MoleQlar — MoleQlar is a data and research-driven longevity company. It provides valuable information and offers consumers lab-tested nutritional supplements. The company focuses on functional medicine with optimized nutrition. Their product range includes Uthever NMN, Resveratrol, Betaine, Carnosine, and more. These products are aimed at lowering biologicalage and promoting health and longevity. MoleQlar also offers health tracking services. The company is certified in Germany and delivers its products EU-wide, including Switzerland.
Qualifyze — Qualifyze (former ChemSquare) was founded out of the Technical University of Darmstadt in September 2017. Today, we are based in Frankfurt am Main, the heart of Germany’s pharmaceutical cluster, where the leading life science companies are based. Our team consists of 16 people with diverse backgrounds and areas of expertise in business,engineering, and technology as well as several strategic partners from the pharma, food and cosmetics industry.
Akhetonics — Creating the first all-optical RISC Processor

Picus Capital is an early-stage technology investment firm with a long-term investment philosophy. We work together with daring technology companies to build successful, global companies challenging the status quo and shaping tomorrow.

Investment focus

Financial Services, Software, FinTech
Seed, Series A, Pre-Seed
Germany, United States, United Kingdom

Portfolio highlights

Hawk — Award-winning AML & CFT technology powered by explainable AI increases your risk coverage, helps you identify more crime, and reduces your false positives.
SmartSolar — SmartSolar is a Saigon-based EnergyTech company working to decarbonise Southeast Asia. With SmartSolar, businesses save on their electricity bill from day 1. SmartSolar is currently busy building the critical financing infrastructure to get SMBs equipped with solar energy. We help our customers save money and enable our partners to reach morecustomers. Renewable energy is at an inflection point across the region and we are on a mission to make it available for everyone.
Niva — Niva's business identity platform enables institutions across the globe to verify more businesses faster, safer, and smarter with AI. Scale your fraud and compliance teams with Niva.

We support exceptional founders in building market leading digital companies.

Investment focus

E-Commerce, Internet, Software
Series A, Seed, Series B
Germany, United Kingdom, United States

Portfolio highlights

Upvest — Upvest empowers financial institutions to offer investment products in their app with a modular, scalable, and accessible API. Upvest brings together everything that’s required to offer a broad range of investment products on the website and app. They are connected to the world’s leading asset providers and exchanges to provide the bestinvestments, at the best prices and execution speed.
Green Fusion — Green Fusion is developing a cloud-based energy manager for the intelligent control of heat, electricity, and e-mobility. The focus here is on hybrid heating systems in buildings such as heat pumps + gas boilers and the coupling to photovoltaic systems and electric vehicle charging stations.
NEURA Robotics — NEURA Robotics is revolutionizing the world of robotics by using cognitive capabilities to bring robots and humans closer together.

IBB Ventures is for all those who make a difference and create a sustainable future. We invest public funds as venture capital and, together with Berlin startups, help to promote our capital as a business location.

Investment focus

Software, Health Care, Internet
Seed, Funding Round, Series A
Germany, United States, United Kingdom

Portfolio highlights

Mediaire — mediaire supports radiologists with AI-based tools for MRI reporting. This enables them to make a more accurate and objective assessment even faster.
ARC Intelligence — ARC Intelligence operates as a supplier of data systems driven by AI for small and medium-sized businesses.
dsb Deutsche Sanierungsberatung — dsb Deutsche Sanierungsberatung provides easy and sustainable solutions for climate-friendly homes energy-efficient renovations for homeowners.

Atlantic Labs supports and invests in mission-driven founders working on transformative technology ventures. <br><br>We partner with founders early, providing the capital, tools and network necessary to growing their companies and accompanying them on their entrepreneurial journey. We are currently active in areas including Digital Health, Future of Work, Machine Learning, Decentralized Networks, Mobility and Industrial Applications.

Investment focus

Software, Health Care, Financial Services
Seed, Pre-Seed, Series A
Germany, Switzerland, United States

Portfolio highlights

Mago — Mago is an AI-native, fully controllable tool revolutionizing video production through style transfer. We empower creators to transform and stylize any video - from live-action to 3D animations - into any aesthetic, seamlessly blending cutting-edge AI with human creativity from concept to final cut.
Prior Labs — Prior Labs develops Tabular Foundation Models (TFMs) like TabPFN to solve AI's structured data challenge, enabling native understanding & boosting ML performance.
Grouphug — Generates memes from the archive of group WhatsApp chats

With a track record of over 20 years in venture capital and experience from more than 200 investments in numerous companies BFB Brandenburg Kapital GmbH (BFB) is the most active equity investor in Brandenburg. BFB invests in fast-growing technology-orientated companies throughout the whole life-cycle. Target sectors are ICT/Digital Economy,Life Science, MedTech, Proptech, Industrial Applications. BFB invests in companies based in or with facilities in Brandenburg. The current VC fund is financed by the European Regional Development Fund (ERDF) an Investitionsbank des Landes Brandenburg (ILB).

Investment focus

Information Technology, Software, Health Care
Seed, Series A, Funding Round
Germany, United Kingdom

Portfolio highlights

family.cards — Family.cards provides elders with barrier-free access to digital solutions and all the tools they need to manage their circumstances.
Green Fusion — Green Fusion is developing a cloud-based energy manager for the intelligent control of heat, electricity, and e-mobility. The focus here is on hybrid heating systems in buildings such as heat pumps + gas boilers and the coupling to photovoltaic systems and electric vehicle charging stations.
Sphingotec GmbH — Improving patient outcomes with innovative diagnostics for critical care: Actionable insights in real-time

Providing capital plus strategic, clinical, operational, financial, and commercial support to deliver the added value inventors seek.

Investment focus

Biotechnology, Health Care, Therapeutics
Series A, Series B, Series C
United States, The Netherlands, Switzerland

Portfolio highlights

Perfuze — Perfuze was founded in 2018 by Wayne Allen and Liam Mullins. Perfuze is located within Galway City in the West of Ireland. The founders have over 30 years combined medtech experience within start-up and large corporations.Perfuze is developing innovative medical technology to treat acute ischemic stroke.Perfuze is developing innovative cathetertechnology to treat acute ischemic stroke. Their technology is intended to provide superior clinical outcomes in shorter procedural times; resulting in safe, cost-effective therapy. Perfuze was founded in 2018 by Wayne Allen and Liam Mullins. The founders have over 30 years combined medtech experience within start-up and large corporations. Perfuze is currently located in the Business Innovation Centre on the campus of the National University of Ireland, Galway, and is in the process of relocating to the IDA Business Park in Dangan, Galway.
Avidicure — Avidicure is developing dual agonistic avidity-engineered multifunctional antibodies, AVC-Boosters, as monotherapy for treatment of cancer
Atalanta Therapeutics — Atalanta was created to address the urgent global need for interventions to treat neurodegenerative diseases.

Empowering visionary founders with pre-seed and seed funding for B2B software innovation. Partner with us to turn your aspirations into thriving businesses. Our expert support ensures your journey to success.

Investment focus

Software, SaaS, Health Care
Seed, Pre-Seed, Series A
Germany, Austria, Switzerland

Portfolio highlights

Briink — Our AI helps private equity firms and companies automate and scale their EU Taxonomy and SFDR assessments. Get in touch today.
mogenius — mogenius radically simplifies cloud infrastructure for software developers. The code to cloud platform provides a completely automated workflow of deploying an application in Kubernetes - with hyperscale cloud resources, built-in CI/CD and DDoS protection so you can start coding in seconds. Never waste time on complicated, error-prone, andrepetitive configurations in your cloud infrastructure again, and focus on what you really love: building great applications.
Enginsight — Enginsight GmbH was founded in August 2017. With a highly motivated team, they are working together on the vision of providing companies with a solution that will enable them to safely and confidently navigate the digital future. Enginsight helps leading companies autonomously monitor and secure their entire IT landscape. Certified and highlytrained employees form the heart of Enginsight, together with partner companies around the globe. They analyze and monitor complete IT landscapes – recognize the connections and dependencies between websites and servers up to IoT-devices. The innovative software platform acts autonomously and points out the critical paths, risks and threats.

Heal Capital is a European venture capital fund backing mission-driven founders with capital and HealthTech-specific expertise, accelerating market access.

Investment focus

Health Care, Artificial Intelligence, Machine Learning
Seed, Series A, Pre-Seed
Germany, United Kingdom, France

Portfolio highlights

Apheris — apheris AI was founded by Robin Rohm and Michael Höh with a shared dream to empower companies to run analytics on decentralized datasets. Michael developed software infrastructure for distributed data during his PhD at Forschungszentrum Julich and his time at BCG. Robin has a background in algebraic theories for data linkage and data privacy andhas experienced the complexity of centralizing sensitive personal healthcare data firsthand in one of his previous start-ups. Through their work, they encountered barriers that limit progress within data driven industries: data is often stored in silos and most companies work in closed data ecosystems. Therefore, Apheris strives to connect the world’s data to extract better insights.
Heim Health — Heim Health is a healthcare firm using technology to deliver scalable, community-based solutions.
Paloma Health — A technology-enabled provider of children's mental health services, starting with autism assessments.

The Boehringer Ingelheim Venture Fund is the strategic venture fund of the Boehringer Ingelheim Corporation.

Investment focus

Biotechnology, Health Care, Therapeutics
Series A, Series B, Seed
United States, Germany, Belgium

Portfolio highlights

Nuevocor — Nuevocor is a preclinical-stage biopharmaceutical company focused on developing gene therapy‑based treatments that have the potential to restore cardiac function in diseased hearts.
Brainomix — Since launching as a spin-out from the University of Oxford in 2010, Brainomix has developed award-winning, AI-powered imaging biomarkers, assisting physicians across the world to make better life-saving decisions. Brainomix seminal product, e-Stroke is a collection of tools that use state-of-the-art AI algorithms to support doctors by providingreal-time interpretation of brain scans to help guide treatment and transfer decisions for stroke patients, allowing more patients to get the right treatment, in the right place, at the right time.
Aignostics — Aignostics is an AI-powered precision diagnostics focused on pathology to assist with drug development and clinical research. Its “explainable” AI overcomes the “black-box” limitations of conventional AI. Based on their patented technology for reverse-engineering the black box, they render diagnostic results explainable in the form of preciseheatmaps and image overlays. These heatmaps allow pathologists to quickly verify the results of the AI, which is crucial, as the pathologist is ultimately responsible for the diagnosis.The company was founded in 2018 and is headquartered in Berlin, Germany.

Investing early in Europe's most passionate founders.

Investment focus

Health Care, Financial Services, FinTech
Seed, Series A, Funding Round
Germany, Austria, United Kingdom

Portfolio highlights

LiveEO — LiveEO is the leading solution provider for AI-powered satellite-based monitoring of large infrastructure networks. Trusted worldwide.
Buynomics — buynomics is the leading solution to optimize your product portfolio. Our clients use buynomics to optimize pricing, promotions, & portfolio architecture.
HelloBetter — HelloBetter (hellobetter.de) was founded in 2015 under the name GET.ON Institut für Online Gesundheitstrainings GmbH (geton-institut.de) by internationally renowned research psychologists, and in close partnership with one of the largest public health care insurance companies in Germany (BARMER). HelloBetter is a pioneer in the field of e-mentalhealth and a leading provider of online mental health courses. Its work has a strong scientific basis – the courses were developed, evaluated, and implemented in a practice setting, and their effectiveness has been proven in 33 randomized controlled trials according to the highest standards of scientific practice. HelloBetter offers the widest range of evidence-based online mental health courses worldwide, with 11 digital courses covering 8 problem areas (stress, depression, insomnia, depression in the case of chronic illness, chronic pain, alcohol consumption, excessive worry, and panic and anxiety).In October 2021, the digital therapeutic 'HelloBetter Stress and Burnout' has been permanently approved by the German Federal Institute for Drugs and Medical Devices (BfArM) as a Digital Health Application (DiGA) and thus is available by prescription free of charge for more than 50 million adults. It is the world’s first and so far only prescription digital therapeutic for the treatment of burnout symptoms.Through diverse cooperations with national and international research groups (including FAU Erlangen, University of Ulm, VU Amsterdam, and Harvard University) HelloBetter finds practical applications for the latest research innovations. Our products and our team have been awarded numerous national and international prizes. These include the Novartis & Sandoz/Hexal Digital Health Prize 2018, the Comenius Award of the European Federation of Psychologists’ Association, and the Good Practice in Mental Health & Wellbeing seal of approval as part of the EU Compass 2018, which recognises high-quality mental health initiatives in Europe in order to guide health care providers to effective and proven services.

Global Asset Fund is a private equity firm based in Germany that finances early and later stage venture investments. The fund enables the development of products and technologies that address a growing market of tomorrow.

Investment focus

Medical, Therapeutics, Biotechnology
Series A, Series B, Funding Round
Germany

Portfolio highlights

Siltectra — SILTECTRA is a high-tech company specializing in kerfless wafering and thinning, an innovative new technology for manufacturing wafers. Kerfless wafering by SILTECTRA is a platform technology which can be used in a wide variety of industries and for many different materials.
Isarna Therapeutics — Isarna Therapeutics has an unmatched commitment to developing selective TGF-β inhibitors to effectively treat ophthalmic diseases. They are advancing a unique pipeline of novel oligonucleotides and combination modalities to transcend clinical response and improve patient outcomes.

Born2Grow is a german venture fund focusing on early stage investments. They invest up to 500k€ in innovative business models. They are based in Heilbronn in Baden-Wuerttemberg. Born2Grow focus on investments lies within the MedTech, BioTech, FinTech area as well as some other online industries

Investment focus

Software, Health Care, Medical
Seed, Series A, Series B
Germany, Finland, United States

Portfolio highlights

Semorai — Semorai - Engineering AI
Doinstruct — Doinstruct offers mobile training solution for frontline workers.
traplinked — Digitale Fallensysteme - Endlich wissen, was los ist! Mit den traplinked Sensormodulen JERRY und TOM erhalten Sie in Echtzeit ein digitales Abbild Ihrer Kontrollpunkte.

The IFB Innovationsstarter is an innovation funding and investment company of the City of Hamburg providing grants and investments.

Investment focus

Software, SaaS, Artificial Intelligence
Seed, Funding Round, Grant
Germany, United States

Portfolio highlights

mo:re GmbH — Mo:re is building the new gold standard for organoid-based drug development by offering a lab platform that industrialises cell culture workflows.
Tomorrow — Tomorrow combines mobile banking with sustainability. Open your sustainable account in minutes & start protecting the climate right away.
Neuralfinity — Build Generative AI Models That Truly Deliver: Create datasets, train from scratch, and evaluate generative AI models like LLMs and VLMs.

Providing capital plus strategic, clinical, operational, financial, and commercial support to deliver the added value inventors seek.

Investment focus

Biotechnology, Health Care, Therapeutics
Series A, Series B, Series C
United States, Germany, United Kingdom

Portfolio highlights

Evommune — Evommune is taking a tissue-based approach to advance insights and accelerate the development of transformative medicines in inflammatory diseases.
Muna Therapeutics — Muna Therapeutics discovers and develops therapies that slow or stop neurodegenerative diseases such as alzheimer’s and parkinson's.
HotSpot Therapeutics — HotSpot Therapeutics is a biotech startup that focuses on the development of allosteric therapies targeting regulatory sites on proteins. It develops a therapy platform to discover medicines and provide proper treatment to identify hotspots and locate pathway treatments for cancer, metabolic and rare diseases, leverages a database of hotspotstructures, harnessing the power of data science in its multidisciplinary approach to drug discovery, and helps patients to get treatment against several diseases.HotSpot Therapeutics was founded in 2017 and is headquartered in Boston, Massachusetts.

SOSV is a global, deep tech venture capital firm that operates the HAX and IndieBio startup development programs focused on human and planetary health. SOSV invests $500,000 in startups at their inception as they onboard either HAX or IndieBio for a 4-6 month period designed to accelerate the raise of their next institutional round. SOSV joins thelater rounds of HAX and IndieBio graduates. HAX, based in a 35,000 sq ft facility in Newark, NJ, is equipped with machine tools, 3D printers, chemical, electrical and mechanical engineering labs, as well as on-staff engineering and design experts. SOSV's IndieBio has locations in NYC and San Francisco, both of which offer extensive services and facilities to founders including on-site BSL-2 labs, well equipped lab benches and hoods, and advanced lab equipment, such as chromatography equipment.

Investment focus

Biotechnology, Health Care, Software
Seed, Convertible Note, Pre-Seed
United States, India, United Kingdom

Portfolio highlights

MixRift — MIXRIFT - game developers specialized in Mixed Reality
unspun — From 3D scan to perfect fitting custom jeans. unspun makes each pair of jeans unique to your actual body and design. On a mission to reduce global carbon emissions by 1%. As seen in Fast Company's World Changing Ideas, Time's Best Inventions, and PopSci's Best of What's New. Welcome to the future of apparel.
Mesa Quantum — Unlock the potential of chip-scale quantum sensing for enhanced Position, Navigation, And Timing capabilities. Explore Mesa Quantum's practical solutions.

The German Federal Ministry of Education and Research funds research programs and institutions, supervises nuclear energy, and establishes educational policy in general.

Investment focus

Biotechnology, Medical, Health Care
Grant, Seed, Series B
Germany, United States, Denmark

Portfolio highlights

NetBird — Wiretrustee is an open-source VPN platform built on top of WireGuard® making it easy to create secure private networks for your organization or home. It requires zero configuration effort leaving behind the hassle of opening ports, complex firewall rules, VPN gateways, and so forth.
CyberTide — CyberTide is an AI-based Data Leak Prevention Solution
NVision Imaging Technologies — NVision Imaging Technologies is leveraging advances in quantum physics to enable the first routine, convenient and affordable use of Magnetic Resonance Imaging (MRI) for assessing early patient response to cancer treatment at the metabolic level.

UNIQA Ventures GmbH is the Venture Capital arm of UNIQA Insurance Group AG, a leading insurance carrier in Central & Eastern Europe and a pioneer in Corporate-backed Venture Capital in Austria and CEE. Based in Vienna, Austria, the firm is investing in outstanding business models driven by strong teams and a clear vision to shape the future ofkey industries. Investment areas are the future of Health, Mobility, Intelligent Home and FinTech/InsurTech as well as enabling technologies such as IoT, Blockchain, ML/AI.

Investment focus

Insurance, Health Care, FinTech
Series A, Seed, Series B
Austria, Germany, United Kingdom

Portfolio highlights

ifeel — Ifeel is the emotional well-being platform for modern organizations. Ifeel is a unique workplace mental health platform for companies.
GoUrban — goUrban offers mobility solutions for sharing operators and B2B fleet management. The way of transportation and mobility is changing rapidly. For operating smarter and using the opportunities of the sharing economy we provide you our fleet management OS.
doctorly — doctorly is a digital medical infrastructure platform. We have a regulated, cloud powered, fully centralised, practice management platform for doctors, a fully connected health app for patients, and an integration platform for the wider industry to natively connect their tools & workflows directly with our doctors & patients.We are backedby amazing investors and driven by a desire to make positive and meaningful changes to the healthcare industry internationally.

VI Partners are Venture Capitalists successfully financing outstanding teams and innovations in the Healthcare and Technology space since 20 years.

Investment focus

Health Care, Biotechnology, Medical Device
Series A, Series B, Series C
Switzerland, Germany, United States

Portfolio highlights

XO Life — XO Life is to build the largest real-world evidence platform for patient insights for all medications and therapies. Together with one of Europe's leading research institutes for patient-centered research, the PROMIS Institute Germany of the Charité, and various pharmaceutical manufacturers, patient experiences are to be recorded in astandardized and systematic manner across a wide range of diseases. Patients are to be enabled to record their therapy course and outcome independently as well as scientifically validated so that these patient insights from real treatment practice can be used in the life science industry and by medical professions.
LeaseTeq — LeaseTeq bietet Privat- sowie Unternehmenskunden das erste komplett digitale Leasingangebot.
Unique — Unlock the power of generative AI in Finance with Unique FinanceGPT. Get custom use cases and accurate insights in a secure, enterprise-ready platform.

WestTech Ventures is a Berlin-based VC firm focused on pre-seed & seed investments primarily in Germany in the fields of B2B SaaS in different verticals, and Enterprise Software as well as Mobility and New Work.

Investment focus

Software, Internet, Information Technology
Seed, Series A, Funding Round
Germany, United States, France

Portfolio highlights

Notch — Boost your deal win rates and customer onboarding with Notch. Create tailored buyer experiences, structured action plans, and gain valuable insights. Try our demo today.
Careloop — Jetzt ist dein Moment Finde deinen Traumjob in der Pflege in Deutschland Careloop | Klett hilft dir, eine attraktiven und sicheren Arbeitsplatz zu finden.
ClimateChoice — The software platform for decarbonizing companies and their supply chains.

Playground is an early-stage investment firm that helps old and new investors and entrepreneurs working at the intersection of bits, atoms, and AI. It focuses on investment, innovation, connected hardware, artificial intelligence, and robotics.

Investment focus

Software, Robotics, Artificial Intelligence
Series A, Seed, Series B
United States, Canada, France

Portfolio highlights

Anjuna — Anjuna confidential cloud software establishes a secure enclave that isolates and encrypts applications and data in runtime, at rest, and on the network for end-to-end data protection
GigaCrop — Perlumi is engineering seeds to turbocharge photosynthesis for unprecedented bounty.
Outpace Bio — Outpace Bio is a biotechnology company that creates smart cell therapies aimed at improving efficacy and safety.It offers a platform that combines custom-designed biological functions with cellular control modalities that program the right response at the right time and place. It creates a mechanism-driven solution tailor-made to improve efficacyand safety. The company collaborates with Lyell Immunopharma to develop and commercialize a potential immune cell therapy for the treatment of cancer, auto-immune diseases, infectious diseases, degenerative diseases, regenerative medicine, metabolic disorders, and genetic disorders, enabling healthcare providers to cure a wide range of diseases as per patient's need.

Backing early-stage startups that drive positive impact for people and planet

Investment focus

E-Commerce, Health Care, Food and Beverage
Seed, Series A, Series B
Germany, United Kingdom, Denmark

Portfolio highlights

Descycle — Descycle e-waste recycling clean technology
CoCoach — CoCoach concentrated on developing a feature-rich web platform specifically for health coaches.
Spot My Energy — The uptake of PV, EVs, home storage, and heat pumps leads to a gigantic need for digital and intelligent metering and for the integration of millions of...

Impacting the future of medicine.

Investment focus

Biotechnology, Health Care, Medical
Series B, Series A, Series C
United States, United Kingdom, The Netherlands

Portfolio highlights

Numab — Numab Therapeutics AG
Verdiva Bio — Verdiva Bio is committed to developing next-generation therapies to help people living with obesity, cardiometabolic disorders, and related complications achieve better outcomes via more patient-friendly therapeutic options.
Orbis Medicines — Orbis Medicines is a novel macrocyclic chemistry and computational platform for high-throughput drug discovery.

The Bertelsmann Investments division pools Bertelsmann's holdings in startups around the world.

Investment focus

Health Care, Artificial Intelligence, Medical
Series B, Series A, Seed
Germany, Israel, Malaysia

Portfolio highlights

deepc — The Radiology AI Platform - Your effortless access to AI
Doccla — We are a start-up. However, our management and advisors combine 100 years of experience in service delivery to large public and private healthcare operators in six European states, as well as several years in wearable device implementation in the global consumer space.
Guardoc Health — Streamlining clinical compliance with AI-driven accuracy in charting to meet regulations, enhance patient care, and optimize revenue management.

Vesalius Biocapital Partners invests in companies active in human health through venture capital funds raised since 2007. They have contributed to developing 20 companies since inception.With more than € 150 million under management in two funds. Vesalius Biocapital Partners plays the role of lead investor in the large majority of its financingrounds.Their companies are based in Europe allowing easy interaction with management.They invest in all stages of development and do not shy away from relatively early-stage projects with a sound proprietary technology and corresponding IP, unique team skills and a clear competitive edge based on solid data.

Investment focus

Biotechnology, Health Care, Medical
Series B, Series A, Series C
Belgium, Germany, The Netherlands

Portfolio highlights

CatalYm — Catalym develops antibodies against a placental factor which is overexpressed by various tumour types.
Caresyntax — Caresyntax is the only enterprise-scale surgical data solution you need to make surgery smarter, safer, and more profitable.
Inflammatix — Inflammatix develops rapid point of care diagnostic tests by reading the immune system, and resolves major clinical health challenges.

Innovative post-revenue startups with first customers trust us as highly reliable investors. We have been an active player in the venture capital market for over 25 years. Due to our evergreen approach, we offer institutional venture capital without the limitations of the usual fund structure. Predominantly we invest straight equity. Additionally,we can offer venture debt to mature startups close to break-even in order to avoid further dilution for founders. Being a private investment company we act as both lead investor or co-investor. We can also fulfill the private lead investor role for public investors like Bayern Kapital. Together we are increasing YOUR company's value.

Investment focus

Software, Information Technology, Health Care
Funding Round, Series A, Series B
Germany, Italy, United States

Portfolio highlights

memtime — memtime shows you everything you worked on during the day. Each program is recorded so that you can quickly remember. Add-on available for any software. | memtime
StoryBox — StoryBox provides a Software as a Service solution for businesses to create, share and structure video content to make it searchable. With the system, companies can create and organize smartphone-based videos for any application scenario. Using the app, videos can be created and shared by every employee using templates. The app suggests picturesettings and scene lengths automatically and offers an automated creation which includes corporate design. The content can be stored in the DSGVO-compliant StoryBox cloud and can be accessed, filtered and analyzed from anywhere. Customers include Iveco, Erste Group, Evonik, Alten, and KTM.
Kloster Kitchen — Kloster Kitchen is a monastery kitchen as the root of unique taste.

Sparkasse Jena is a German savings bank offers a collection of financial products and services to private, retail, and corporate customers.

Investment focus

Medical, Shopping, E-Commerce
Seed, Series A, Series C
Germany, United States

Portfolio highlights

ShopCo Technologies — Shop uses Artificial Intelligence to empower online shopping experience for customers. It is a universal shopping cart browser extension that keeps all the items of its users across the web in one spot. Stores can be registered online and without any hassle. It helps its users browse through a wide range of online stores and checkout from one spot.The company gives ability to connect to all its users existing retailer accounts. It also secures data with encryption methods and two-step verifications. Shop is a U.S.-based company that was founded in 2014 by Jay Habib.
NovaPump — The NovaPump GmbH is a cardiology company based in Jena/Germany devoloping cutting-edge therapeutical solutions in the field of non-invasive and percutaneous circulation support. The so called PERKAT (PERKutane KATheterpumpe) technique will be offered as pLVAD & pRVAD heart pumps for acute left or right heart patients within the nextyears. PERKAT works together with the current IABP technique (intra aortic balloon pump with about 200,000 cases p.a. internationally) and is the only-one catheter-based & self-expanding, pulsatile & ECG-triggered, cost-effective heart pump technique with a high pump performance. PERKAT is not available on the market so far. Articles in leading scientific journals and presentations at the top four international cardiology conferences in the last years show the medical need, the development status and the technological and medical advantages of PERKAT.
Dynamic42 — Dynamic42 provides, customizes innovative 3D microphysiological in vitro test systems recreating human organ key functions. It develops and markets novel, three-dimensional, human organ models (scalloped organ-on-chip technology) for preclinical research and developmental, as well as for testing novel pharmaceutical products,chemicals, and food additives. It is specialized in the area of organ-on-chip technology in the integration of the immune system, which plays a significant role in the occurrence of adverse effects of drugs and has been neglected in the industry and in two-dimensional test systems.

BackBone Ventures' focus are early-stage investments, primarly in the area of innovative ICT, FoodTech and disruptive technologies in DACH & Israel. Committed to achieve a positive impact for the next generation by empowering access to proficient ventures investments.

Investment focus

Information Technology, Artificial Intelligence, Software
Seed, Pre-Seed, Funding Round
Switzerland, Germany, Israel

Portfolio highlights

Syn2core — We are a startup in stealth mode, working on an AI co-pilot to empower frontline workers in automotive.
Cloudsquid — is an an artificial intelligence based revenue orchestration company intended for companies with usage-based pricing models.
CROWN — Drive savings and supplier competition with CROWN's eAuction service. Smart reverse auctions built for procurement teams. Book your free demo today.

Lauder Partners, LLC is an entity investing in various realms of the technology field. Lauder invest both directly in companies as well as in funds - both venture and others. Since it primarily invests the capital of Gary Lauder and family members, we don't provide much information to the public.

Investment focus

Software, Internet, Health Care
Funding Round, Series B, Seed
United States, United Kingdom, China

Portfolio highlights

Lassen Peak — PUBLIC SAFETY INNOVATION Threat detection for a safer world Once in a great while, the path of advanced technology unexpectedly joins the basic needs of society. Learn More https://www.lassenpeak.com/wp-content/uploads/2023/12/Globe3.m4v Linkedin Envelope
OccamzRazor — OccamzRazor combines machine learning and first-in-class biological techniques to improve outcomes in drug discovery and development. Our analysis pipeline consists of two proprietary technologies, Panoramic AI and RazorBrain. Together, they are designed to extract data from unstructured text sources (publications, patient reported outcomes, etc.)and join them with structured data (genomics, proteomics, phenomics, etc.) to generate stronger drug discovery hypotheses and more valuable insights. Successful applications include data extraction and curation from biomedical text, novel target identification, and drug repurposing/repositioning.
NVision Imaging Technologies — NVision Imaging Technologies is leveraging advances in quantum physics to enable the first routine, convenient and affordable use of Magnetic Resonance Imaging (MRI) for assessing early patient response to cancer treatment at the metabolic level.

The TUDAG group of the TU Dresden is a combination of past ten companies whose job it is to the knowledge of the university market. The aim is to encourage industry and in particular SMEs in the development of new technologies and innovative products. Also for the training of highly qualified staff provides the group TUDAG extensive benefits.Morethan 500 scientists, engineers, project managers and lecturers of the group realize TUDAG individual innovations across the entire value chain. Here, they work in interdisciplinary teams to work closely with scientists from the Technical University of Dresden and other scientific institutions.

Investment focus

Electronics, Manufacturing, Biotechnology
Seed, Pre-Seed, Series C
Germany

Portfolio highlights

DyNAbind — DyNAbind is a privately-held biotech company from Dresden offering partnerships and solutions for better drug discovery with Dynamic DNA-Encoded Library (D-DEL) technologies.We have overhauled the DEL discovery process by introducing proprietary innovations in library design, selection and validation, all of which lead to a faster path tohigh-quality, relevant starting points for medicinal chemistry – and the only DEL platform on the market fully designed to integrate with a fragment-based discovery methodology.
Senorics — Senorics is a Spin-off of the Integrated Center of Applied Physics and Photonic Materials of the University of Technology Dresden, Germany, founded in 2017.The company specializes in designing and manufacturing optical spectroscopic sensor solutions for industrial applications, such as quality control and process monitoring. Products and servicesinclude customized sensors, corresponding software and calibration models. Developed proprietary new sensor technology for detecting visible and near-infrared light.
SmartNanotubes Technologies — SmartNanotubes Technologies is a start-up company's odor sensor works on the basis of nanotechnology.

Global Life Science Ventures (GLSV) was a venture capital fund focusing exclusively on the life sciences. GLSV was dedicated to supporting early-stage groups, originating from universities, scientific institutions or industry. The fund also invested in selected later stage companies, including buy-outs. For this purpose, GLSV provided finance,advice and access to expertise and networks. The group advised and managed funds totaling more than € 200 million. With offices in Germany and Switzerland, GLSV acted as one team with a global perspective. The first fund started its activities in 1996 and invested in 18 companies. The second fund GLSV II started in 2001 and invested in 18 companies primarily in Europe and the US. After termination of the investment period, the fund exited the remaining assets in 2015 and is in liquidation.

Investment focus

Biotechnology, Health Care, Medical
Series C, Series A, Series B
United States, Germany, Denmark

Portfolio highlights

Action Pharma — Action Pharma A/S operates as a research and development focused biotechnology company. It discovers and develops new drugs and treatment concepts to treat cardiovascular disease and inflammatory diseases, as well as metabolic diseases, such as type-II diabetes and obesity. The company's product pipeline includes AP214, a modifiedÃMSH-peptide analogue for the treatment of post-surgical kidney injury associated with cardiac surgery; and AP1030 and AP11 series, oral anti-diabetic (OAD) for the treatment of type-II diabetes associated with overweight/obesity. Its product pipeline also comprise AP1189, an oral anti-inflammatory compound for the treatment of inflammatory diseases, such as inflammatory bowel disease and rheumatoid arthritis; and AP405, a modified MSH peptide analogue for the treatment of inflammatory skin diseases, such as atopic dermatitis. The company was founded in 2000 and is based in Holte, Denmark.
Coapt Systems — Coapt Systems, Inc. engages in the design, development, manufacture, and marketing of bio-absorbable implants for use in soft tissue fixation during facial cosmetic surgery procedures. It offers ENDOTINE Forehead 3.0, a bioabsorbable brow fixation device; ENDOTINE Forehead Instrument Kits that comprise insertion tools, drill bits, and sterilizationtrays with lids; ENDOTINE Triple 3.0, the bioabsorbable brow fixation devices with disposable drill bits and insertion tools; ENDOTINE TransBleph 3.0, a bioabsorbable upper lid and brow fixation devices. The company also provides ENDOTINE Midface ST 4.5, a bioabsorbable midface suspension devices; ENDOTINE Ribbon, a bioabsorbable fixation devices; Coapt Manual Surgical Drills, the manual surgical hand drills for use with ENDOTINE implants; and SurgiWire Incisionless Dissectors, the subcutaneous The Endotine product line was bought by MicroAire, a surgical device manufacturer in Charlottesville, VA, in August 2010.
Santaris Pharma — Spearheading RNA molecule research since 2003, our site in Copenhagen is focused on leading chemistry for targeting any type of transcribed RNA using short synthetic single-strand oligonucleotides. Here, our experts in the field pioneered our core technology platform of locked nucleic acids (LNA) and antisense oligonucleotides (ASO).

We effectively support start-ups through early-stage capital, network, know-how, follow-up financing and personality development.

Investment focus

Manufacturing, Medical, Internet
Seed, Pre-Seed, Convertible Note
Germany

Portfolio highlights

BDK Group — Autoglas der Zukunft
Infrasolid — Innovative infrared sources for gas detection & spectroscopy. Infrasolid's infrared radiation sources are based on a patented nanotechnology in combination with the self-supporting monolithic structure.
Suburban Seafood — Premium producer of shrimp larvae and prawns.

Build your next company with Antler, a global day zero investor enabling exceptional founders to start great companies, from the very beginning. Apply now!

Investment focus

Software, Information Technology, Artificial Intelligence
Pre-Seed, Seed, Series A
United Kingdom, Singapore, Australia

Portfolio highlights

GenPage — GenPage is a SaaS platform that supercharges outreach & account-based marketing (ABM) campaigns with personalized landing pages that captivate, engage, and close. We help our users create unique experiences at scale for every prospect with AI - and win more deals.
Lodgicl — Lodgicl streamlines the insurance supply chain to enhance the claims experience for policyholders, insurers, and partners.
FoodHealth — Your home for healthy eating made simple. Powered by a team of food lovers & Dietitians, we help you find the right food for your body. And then we deliver that food directly to your doorstep!

Springboard Health Angels is a Berlin based Angel group to invest in early stage Digital Health startups

Investment focus

Health Care, Software, Biotechnology
Seed, Pre-Seed, Funding Round
Germany, United States, Sweden

Portfolio highlights

deepeye — 66% of blindness in Europe and the US is caused by retinal diseases - and thus preventable.
Vivalyx — Vivalyx Omnisol will be a process- and cost-effective one-stop solution for all preservation applications, allowing NMP without the use of blood or human products.
PharmaCCX — Welcome to CCX - digital tools purposely-built for market access. Explore our 4 transformative tools, and industry-leading expertise.

Birds of a feather flock together? Not our style! We promote healthcare startups who believe in their vision and want to be a success at it. DocCheck Guano is a hatchery for precocial birds aiming to land in the market. We provide the ideal fertiliser for startups: capital, know-how, market access and network. Oh, and our focus is on seed funding.

Investment focus

Health Care, Medical Device, Mobile Apps
Seed, Funding Round, Pre-Seed
Germany, Spain, The Netherlands

Portfolio highlights

Amparo — We empower amputees so they can live life to the full. Amparo is a developer, manufacturer and distributor of prosthetic components. It developed the Confidence Socket, which is the interface between the patient's residual limb and the prosthetic leg itself. 1) The fitting process is as fast as 1h time; 2) The material can be remolded 10times, saving huge costs of health providers; and 3) All tools fit into a sports bag. making it possible to service amputee anywhere in the world.
medflex — medflex offers secure medical communication via messaging, video calls, and video consultation services.
Mammoth Hunters — Mammoth Hunters is a 360° wellness solution offering accessible functional training, natural nutrition and lifestyle advice packaged as a mobile/web based SaaS. The founders come from a scientific background and use discoveries in human physiology and evolution to create personalized fitness journeys. The program is designed toeliminate all barriers that prevent people from leading a healthy lifestyle - lack of time, knowledge and motivation. The company employs 12+ people in Barcelona Spain and has key partnerships with fitness experts, healthcare companies, and sports technology companies.

The Auxxo Female Catalyst Fund is a sector agnostic pre-seed and seed stage investors that backs female (co-)founded startups in Europe.

Investment focus

Software, Health Care, FinTech
Seed, Pre-Seed, Series A
Germany, United Kingdom, France

Portfolio highlights

BIOVOX — Mit Biokunststoff aus nachwachsenden Rohstoffen bis zu 85% CO2 einsparen. Hergestellt unter ISO 13485, biokompatibel nach ISO 10993.
Recyda GmbH — All-in-one Packaging Recyclability Management
Exakt Health — Exakt Health is the physio app for sports injuries. The Exakt Health app guides users through self-diagnosis for frequent sports injuries and then creates an individualized rehabilitation plan.

APX Ventures offers digital solutions, including pay-per-click, custom web services, SEO, and cloud services.

Investment focus

Software, Artificial Intelligence, Health Care
Seed, Series A, Pre-Seed
Germany, Austria, United Kingdom

Portfolio highlights

sewts — Founded in 2019 and based in Munich, sewts GmbH provides cutting-edge perception software, pushing the boundaries of robotics in processing of easily deformable materials. sewts has developed and demonstrated a unique technology that uses high-precision finite element method (FEM) simulations to efficiently train machine learning algorithms. Theintelligent software solution enables countless applications in industrial automation like the handling of textiles in industrial laundries or the manufacturing of garment. sewts is backed by APEX Ventures, Bayern Kapital, High-Tech Gründerfonds, UnternehmerTUM Initiative for Industrial Innovators and a couple of highly experienced business angels.
Senisca — Developing a new generation of senotherapeutic interventions to target the diseases and aesthetic signs of ageing.
Zetta Genomics — At Zetta Genomics our products and services are empowering the application of genomic data to improve health outcomes for millions of patients around the world.

KHAN Technology Transfer Fund operates as an investment firm.

Investment focus

Medical, Therapeutics, Biotechnology
Seed, Series A
Germany, Czech Republic, United Kingdom

Portfolio highlights

Nodus Oncology — Nodus Oncology Developing the DDR targeting therapies.
Casinvent Pharma — Casinvent Pharma develops new therapeutic options for the treatment of selected malignancies.
Qli5 Therapeutics — Qli5 Therapeutics develops a new class of proteasome inhibitors with high selectivity and unique, non-covalent binding properties.

Investors by industry

Artificial intelligence